Clinical Trial Update: Dupilumab in the Treatment of Pediatric Alopecia Areata [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dupilumab for pediatric alopecia areata is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Alopecia Areata | Phase 2 | Status: RECRUITING